• Lead team that focuses on multiple disciplines ranging from KOL Influence in Rheumatology and Retina, Data & Analytics, New Product Planning as well as Corporate Development and Operations • Co-Lead the Global M&A Screening team and currently lead the Integration team for the Aciex Therapeutics acquisition• Deal Team: In- Licensing RetnaGene• Deal Team: Acquisition of Aciex Therapeutics• Deal Team: Sale of Nicox Inc. to Valeant

• Responsible for Commercial Strategy and Evaluation of Opportunities both for In/Out Licensing of Technology as well as M&A• Deal Team: In- Licensing of Sjo• Commercial Alliance Management with Bausch & Lomb• Responsible for New Product Planning of current pipeline therapeutics and diagnostics

• Globally responsible for Collaborative Solutions within the Commercial Pharmaceutical Value Stream• Collaborated and developed Two key Solutions, mFolio and eHealth within the Industry Solutions Group• Areas of focus; Mobility, PRM, Portal, Strategic Initiatives and Domain Lead engagements

• Globally responsible for Sales & Marketing Domain Consulting within Life Sciences Vertical • Worked with Global Pharma Majors on variety of Transformational Initiatives• Areas of focus; Global Strategic Pricing, Business Process Optimization, Brand Initiatives

Provided external advice for project focused on Therapeutic Assessment, Opportunity Assessment for In-Licensing and Commercial Strategy

• Responsible for Commercial Due Diligence on all Pulmonary Asset Opportunities for In-licensing. Lead Global Valuation of Cystic Fibrosis program to support EX-US Partnering deal terms as well as Global Forecast. NPV Analysis on various Franchise Development Opportunities with existing CF Program. • Lifecycle Management for core development programs including impact on Intellectual Property, Market Exclusivity,Commercial Impact and Clinical Development• Built relationships with Key Opinion Leaders around the world to support positioning and scientific messaging for the Cystic Fibrosis program. Authored product plan and Global Commercial Analysis to support Market Development. Commercial member of several cross functional sub teams, including Project Leadership, Manufacturing, Strategy and Launch.• Project lead on various Branding Activities including; Trade Name, Class Name, Package Design. Branded Phase III Studies to correlate with Product Positioning and Class Name for unilateral messaging in the public domain. Developed Strategic Alliances with multiple Global Patient Advocacy groups in support of our CF Program.• Sold Restasis®, Elestat® and Launched Azasite® to Ophthalmologists and select high prescribing Optometrists in Minnesota, North Dakota, South Dakota and Montana. Multiple award winner including back to back Circle of Excellence honors in 2007 & 2008. Established as leader in the sales team with peer nomination to the Field Advisory Board and winning National Sales Award by increasing sales >150% in 1st year. Generated revenue of over $1.25mm in designated territory while consistently achieving sales quotas. Product Launch experience with novel antibiotic in 2007. • Instrumental in forming strategic alliance between Inspire and Minnesota Eye Consultants, the preeminent Cataract/Refractive Surgery Practice in the United States. Established pivotal business relationships with National Key Opinion Leaders within 6 months of joining the company.

• Sold Aricept®, Neurontin® and Relpax® to Neurologists, Psychiatrists, and select high prescribing PCP’s. Multiple award winner including Representative of the Quarter, 2004 Solution Mentality and 2005 Winner Select. Achieved outstanding performance with primary product, Aricept® by achieving a #4 ranking in the Northeast during 2005.• Achieved multiple Management Leadership Awards from Pfizer Regional Office while exceeding sales quotas in 10 of 11 Quarters. Recognized as District Leader in Territory Planning due to numerous Reimbursement challenges that were overcome through creative solutions.

• Defined new business processes around the firms InvestOne® portfolio platform. Established various initiatives from an operational perspective to enhance reconciliation of mutual fund transactions on a daily and monthly basis.• Delivered strategic and tactical initiatives to improve contact center operations with regards to appropriate accounting around mutual fund trades. Refined process to reconcile mutual fund holdings from paper to electronic through development of macro implementation in Visual Basic.

• Responsibilities included reconciliation of mutual fund holdings and daily net asset values of $3 Billion in Holdings. Worked with Portfolio Managers and Traders to complete a $500 million Mortgage Back Security trade within Stable Value Fund.• Accountable for weekly analysis on Canadian Managed Income Fund as well as Foreign Exchange Swaps for Stable Value Group.